Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model.

Blood Transfus 2019 05 9;17(3):237-246. Epub 2018 Nov 9.

Coagulation Laboratory, Department of Pathology, "Mater Dei" Hospital, Msida, Malta.

Background: Fibrinogen is produced in the liver and tends to be reduced in liver cirrhosis. Quantitative and qualitative tests exist to measure fibrinogen. We aimed to validate the functional fibrinogen thromboelastography assay (FF-TEG) and propose a new model to estimate fibrinogen levels via the Clauss method (Clauss) using data from a prothrombin time-derived fibrinogen assay (PT-Fg) in patients with liver cirrhosis.

Materials And Methods: Clauss, PT-Fg, fibrinogen antigen (Fib-Ag) and FF-TEG were studied in 55 patients with liver cirrhosis (26 with Child-Turcotte-Pugh [CTP]-A disease, 14 with CTP-B and 15 CTP-C) and 20 healthy individuals.

Results: The results of all four assays correlated strongly with each other, but gave significantly different mean levels in all cohorts. PT-Fg gave the highest levels whereas the Clauss gave the lowest levels. The FF-TEG performed well with results which were in between the Clauss and the PT-Fg. Significant differences were only observed between CTP-A and CTP-C for the Clauss, PT-Fg and Fib-Ag but not functional fibrinogen level. We devised a simple linear regression model in order to estimate Clauss from the PT-Fg.

Discussion: The results of the FF-TEG correlate well with those of routine fibrinogen assays in patients with liver cirrhosis. However, the FF-TEG assay does not discriminate between early and late stages of disease, pointing to a preserved fibrin clot strength in cirrhosis. Through linear regression models, fibrinogen levels can be accurately estimated using the Clauss method based on fibrinogen levels obtained in the cheaper PT-Fg.

Download full-text PDF

Source
http://dx.doi.org/10.2450/2018.0105-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596371PMC
May 2019

Publication Analysis

Top Keywords

patients liver
12
liver cirrhosis
12
fibrinogen levels
12
functional fibrinogen
12
fibrinogen
12
clauss pt-fg
12
fibrinogen thromboelastography
8
thromboelastography assay
8
clauss method
8
clauss
8
levels clauss
8
linear regression
8
pt-fg
6
liver
6
levels
6
ff-teg
5
levels ff-teg
4
lowest levels
4
pt-fg fib-ag
4
pt-fg differences
4

Similar Publications

Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.

Shock 2013 Jan;39(1):45-9

Department of Surgery, University of Colorado Denver, Aurora, CO, USA.

Thromboelastography (TEG) is emerging as the standard in the management of acute coagulopathies in injured patients. Although TEG is sensitive in detecting abnormalities in clot strength, one shortcoming is differentiating between fibrinogen and platelet contributions to clot integrity. Current American algorithms suggest platelet transfusion, whereas European guidelines suggest fibrinogen concentrates for correcting low clot strength. Read More

View Article and Full-Text PDF
January 2013

Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis.

J Trauma Acute Care Surg 2014 Feb;76(2):255-6; discussion 262-3

From the Department of Surgery, San Francisco General Hospital, University of California, San Francisco, San Francisco, California.

Background: Thromboelastography (TEG) is used to diagnose perturbations in clot formation and lysis that are characteristic of acute traumatic coagulopathy. With novel functional fibrinogen (FF) TEG, fibrin- and platelet-based contributions to clot formation can be elucidated to tailor resuscitation and thromboprophylaxis. We sought to describe the longitudinal contributions of fibrinogen and platelets to clot strength after injury, hypothesizing that low levels of FF and a low contribution of fibrinogen to clot strength on admission would be associated with coagulopathy, increased transfusion requirements, and worse outcomes. Read More

View Article and Full-Text PDF
February 2014

A comparative study of fibrinogen measurement using TEG® functional fibrinogen and Clauss in adolescents undergoing scoliosis surgery.

Int J Lab Hematol 2020 Aug 28;42(4):380-386. Epub 2020 Mar 28.

Department of Anesthesiology, Peking Union Medical College Hospital, Beijing, China.

Introduction: Thromboelastography (TEG®) functional fibrinogen (FF) test is a point-of-care test for fibrinogen measurement and is preferred for its rapid turnaround time. This study was designed to compare TEG® functional fibrinogen level (FLEV) with classic Clauss fibrinogen in patients undergoing scoliosis surgery and to evaluate the concordance between the two methods.

Methods: Patients in this study were part of a larger study evaluating the effect of fibrinogen concentrate (FC) supplementation on perioperative blood loss in scoliosis surgery. Read More

View Article and Full-Text PDF
August 2020

A comparison of fibrinogen measurement using TEG(®) functional fibrinogen and Clauss in cardiac surgery patients.

Int J Lab Hematol 2015 Aug 6;37(4):459-65. Epub 2014 Nov 6.

Clinical Analyst, LHCH, Liverpool, UK.

Introduction: Viscoelastic methods of estimating fibrinogen measure clot formation under platelet inhibition; these methods are gaining in popularity because of their convenience and speed. The aim of this study was to compare the results of the TEG(®) functional fibrinogen (FF) assay with the Clauss fibrinogen method in a group of patients presenting for cardiac surgery and to assess whether they gave equivalent results.

Methods: As part of a larger study evaluation a transfusion algorithm for use in cardiac surgery, 320 paired samples of TEG(®) FF and Clauss fibrinogen were compared. Read More

View Article and Full-Text PDF
August 2015